Medytox Inc

Medytox Inc (Medytox) is a pharmaceutical firm based in South Korea that develops, manufactures, and markets biopharmaceutical medicines. Botulinum toxin, hyaluronic acid filler, and medical devices are among the products offered by the company. Neuronox, innotox, and coretox are botulinum toxin-type products. Medytox hyaluronic acid filler gives neuramis a boost. Neurakin cream is also available from the manufacturer. The business offers comfortdual, a medical device that uses high-frequency electricity to coagulate tissue. It operates in Taiwan, China, Hong Kong, Japan, and Thailand, with manufacturing factories, research and development centers, and joint venture firms.

Medytox has grown dramatically since the introduction of botulinum toxin type A Meditoxin® in 2006. Medytox has approximately 40% of the Korean market share since 2009 and is likely to grow even more with the addition of new indications. Medytox has a significant market share in the global botulinum industry. With the goal of expanding into the United States and Europe, it intends to exceed 10% of the worldwide market share through the launch of newly developed botulinum toxin products.

Medytox will expand as a biopharmaceutical industry leader in the future by challenging with a desire for the worldwide market. Medytox presently exports products to 60 countries, including Japan and Brazil. In addition, the company is working hard to break into the markets in the United States and Europe in the near future. Based on these findings, Medytox will be recognized as a global leader in biopharmaceuticals.

Founded: 2000
Headquarters: Chungbuk, South Korea
Website: http://www.medytox.com/